Skip to main navigation

Main Nav

About Us
Scientific Platform
Our Pipeline
Career Opportunities
Investors & Media

Press Releases

IR Nav

Overview
Press Releases
Events
Presentations
Annual Reports
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
FAQs
Email Alerts
Investor Contact

Shareholder Tools

Press Releases

Year

Gritstone Oncology Advances into Phase 2 Expansion Cohorts for its Personalized Neoantigen Immunotherapy GRANITE and its Off-the-Shelf Neoantigen Immunotherapy SLATE

November 2, 2020

Gritstone Oncology Announces Updated Presentation Time at Cantor Virtual Global Healthcare Conference

September 15, 2020

Gritstone Oncology to Webcast Presentations from Two Upcoming Investor Conferences in September

September 8, 2020

Gritstone Oncology Reports Second Quarter Financial Results and Recent Highlights

August 5, 2020

Gritstone Oncology to Present at Two Upcoming Investor Conferences in August

August 3, 2020

Gritstone Oncology to Present Clinical Data from Ongoing GRANITE and SLATE Phase 1 Studies During Investor Webcast on July 13

June 24, 2020

Gritstone Oncology Announces the Addition of Jean-Charles Soria, M.D., Ph.D., to its Scientific Advisory Board

June 10, 2020

Gritstone Oncology to Present at Two Upcoming Investor Conferences in June

June 4, 2020

Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights

May 7, 2020

Gritstone Oncology Announces the Appointment of Dr. Elaine V. Jones as Chair of the Board of Directors

May 1, 2020

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Next page
Last page

© 2021 Gritstone Bio |

Footer Links

Privacy Policy
Terms of Use
Contact

socials

Top